Announcements

4 June 2025
Journal of Pharmaceutical and BioTech Industry | Scope Update

To further enhance the quality of the Journal of Pharmaceutical and BioTech Industry (JPBI, ISSN: 2813-9380) and the papers published in it, under the guidance of our Editor-in-Chief, Prof. Dr. Bozena B. Michniak-Kohn, the journal has updated and revised its aims and scope. The original scope and the updated version are listed below:

Scope (new version):

Scope (old version):

  • Pharmaceuticals, biopharmaceuticals, and active pharmaceutical ingredient production;
  • Early drug discovery and development;
  • Product characterization and pre-clinical testing;
  • Drug delivery systems and drug design;
  • Formulation, device, and packaging development;
  • Process development, optimization, scale-up, and manufacturing;
  • Biotechnology, applied immunology, human gene therapy, and molecular diagnostics/therapeutics;
  • Pharmacokinetics, pharmacodynamics, and metabolism–transport of drugs;
  • Mathematical modeling, simulations, and digital twins;
  • Natural products, marine biotechnology, and green chemistry;
  • Toxicology;
  • Clinical trials for pharmaceuticals and biopharmaceuticals;
  • Patent analysis, regulatory and legislative approval issues.
  • Early drug discovery and development;
  • Product characterization and pre-clinical testing;
  • Drug delivery systems and drug design;
  • Active pharmaceutical ingredient (API) production;
  • Formulation, device, and packaging development;
  • Process development, optimization, scale-up, and manufacturing;
  • Pharmaceutics and biopharmaceutics;
  • Mathematical modeling, simulations, and digital twins;
  • Pharmacokinetics, pharmacodynamics, and metabolism–transport of drugs;
  • Pharmaceutical nanotechnology and biotechnology;
  • Natural products and green chemistry;
  • Toxicology;
  • Clinical trials;
  • Regulatory and legislative approval;
  • Patent analysis.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/jpbi/about.

JPBI Editorial Office

More News...
Back to TopTop